C

Cardea Bio Inc.

27 employees

Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.

Basic info

Industry

semiconductor manufacturing

Sectors

Biotechnology
Digital Biology
CRISPR
Semiconductor
BPU
Internet of Biology
Biology
Manufacturing
multiomics
Biosignal Processing Unit
Information Technology

Date founded

2019

Funding rounds raised

Total raised

$7.8M

from 13 investors over 13 rounds

C

Cardea Bio Inc. raised $1.1M on May 3, 2022

Investors: Bill & Melinda Gates Foundation

C

Cardea Bio Inc. raised $6.5M on January 12, 2021

Investors: Taihill Venture and 3E Bioventures Capital

C

Cardea Bio Inc. raised undisclosed on October 23, 2020

Investors: Sand Hill Angels

C

Cardea Bio Inc. raised $7.5M on September 17, 2020

Investors: Taihill Venture, Table Mountain Capital LLC, Serra Ventures, Foothill Ventures, - and PhotonFund

C

Cardea Bio Inc. raised $7.8M on March 22, 2019

Investors: Evolution VC Partners and Serra Ventures

C

Cardea Bio Inc. raised undisclosed on May 1, 2014

Investors: EvoNexus

FAQ